EP3004299A1 - Processes for selective extraction of unsaponifiable materials from renewable raw materials by reactive trituration in the presence of a cosolvent - Google Patents
Processes for selective extraction of unsaponifiable materials from renewable raw materials by reactive trituration in the presence of a cosolventInfo
- Publication number
- EP3004299A1 EP3004299A1 EP14733255.5A EP14733255A EP3004299A1 EP 3004299 A1 EP3004299 A1 EP 3004299A1 EP 14733255 A EP14733255 A EP 14733255A EP 3004299 A1 EP3004299 A1 EP 3004299A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- unsaponifiable
- raw material
- avocado
- extraction
- unsaponifiable fraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 115
- 239000002994 raw material Substances 0.000 title claims abstract description 80
- 230000008569 process Effects 0.000 title claims abstract description 61
- 238000000605 extraction Methods 0.000 title claims abstract description 48
- 238000001665 trituration Methods 0.000 title claims abstract description 31
- 239000006184 cosolvent Substances 0.000 title claims abstract description 26
- 239000000463 material Substances 0.000 title description 7
- 150000002632 lipids Chemical class 0.000 claims abstract description 104
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 61
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 55
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 30
- 150000002576 ketones Chemical class 0.000 claims abstract description 28
- 150000001299 aldehydes Chemical class 0.000 claims abstract description 27
- 230000006870 function Effects 0.000 claims abstract description 19
- 239000003054 catalyst Substances 0.000 claims abstract description 18
- 239000012074 organic phase Substances 0.000 claims abstract description 13
- 239000003495 polar organic solvent Substances 0.000 claims abstract description 7
- 150000003573 thiols Chemical class 0.000 claims abstract description 4
- 150000002118 epoxides Chemical class 0.000 claims abstract 5
- 244000025272 Persea americana Species 0.000 claims description 81
- 235000008673 Persea americana Nutrition 0.000 claims description 81
- 239000012071 phase Substances 0.000 claims description 74
- 239000000203 mixture Substances 0.000 claims description 46
- 238000010438 heat treatment Methods 0.000 claims description 34
- 235000013399 edible fruits Nutrition 0.000 claims description 33
- 238000007127 saponification reaction Methods 0.000 claims description 27
- 230000018044 dehydration Effects 0.000 claims description 23
- 238000006297 dehydration reaction Methods 0.000 claims description 23
- 125000003396 thiol group Chemical class [H]S* 0.000 claims description 21
- 238000000199 molecular distillation Methods 0.000 claims description 18
- 230000003750 conditioning effect Effects 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 238000000638 solvent extraction Methods 0.000 claims description 12
- 238000000622 liquid--liquid extraction Methods 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 239000003960 organic solvent Substances 0.000 claims description 10
- 230000001143 conditioned effect Effects 0.000 claims description 9
- 150000001335 aliphatic alkanes Chemical group 0.000 claims description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 150000001412 amines Chemical group 0.000 abstract description 22
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 60
- 150000001875 compounds Chemical class 0.000 description 49
- 235000019441 ethanol Nutrition 0.000 description 49
- -1 terpene alcohols Chemical class 0.000 description 46
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical class OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 39
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 38
- 239000002904 solvent Substances 0.000 description 37
- 150000002240 furans Chemical class 0.000 description 33
- 235000014113 dietary fatty acids Nutrition 0.000 description 31
- 239000000194 fatty acid Substances 0.000 description 31
- 229930195729 fatty acid Natural products 0.000 description 31
- 238000004821 distillation Methods 0.000 description 27
- 239000000047 product Substances 0.000 description 27
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 26
- 239000003921 oil Substances 0.000 description 25
- 235000019198 oils Nutrition 0.000 description 25
- 150000002191 fatty alcohols Chemical class 0.000 description 24
- 239000002243 precursor Substances 0.000 description 24
- 239000000470 constituent Substances 0.000 description 23
- 150000002924 oxiranes Chemical class 0.000 description 21
- 150000004665 fatty acids Chemical class 0.000 description 20
- 241001465754 Metazoa Species 0.000 description 16
- 239000002253 acid Substances 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 238000001035 drying Methods 0.000 description 15
- 150000002148 esters Chemical class 0.000 description 14
- 239000003925 fat Substances 0.000 description 14
- 235000019197 fats Nutrition 0.000 description 14
- 235000011187 glycerol Nutrition 0.000 description 14
- 238000001704 evaporation Methods 0.000 description 13
- 230000008020 evaporation Effects 0.000 description 13
- 238000005119 centrifugation Methods 0.000 description 12
- 238000005809 transesterification reaction Methods 0.000 description 12
- 125000005907 alkyl ester group Chemical group 0.000 description 11
- 239000002537 cosmetic Substances 0.000 description 11
- 150000003626 triacylglycerols Chemical class 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 229930182558 Sterol Natural products 0.000 description 10
- 235000003702 sterols Nutrition 0.000 description 10
- 235000007586 terpenes Nutrition 0.000 description 10
- 238000007670 refining Methods 0.000 description 9
- 150000003505 terpenes Chemical class 0.000 description 9
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 8
- 235000008504 concentrate Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000000344 soap Substances 0.000 description 8
- 238000004809 thin layer chromatography Methods 0.000 description 8
- 235000013311 vegetables Nutrition 0.000 description 8
- 241000282414 Homo sapiens Species 0.000 description 7
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 7
- 230000001476 alcoholic effect Effects 0.000 description 7
- 125000001931 aliphatic group Chemical group 0.000 description 7
- 238000004332 deodorization Methods 0.000 description 7
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 229940031439 squalene Drugs 0.000 description 7
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 7
- 125000000217 alkyl group Chemical group 0.000 description 6
- 235000021302 avocado oil Nutrition 0.000 description 6
- 239000008163 avocado oil Substances 0.000 description 6
- 238000004807 desolvation Methods 0.000 description 6
- 229930195733 hydrocarbon Natural products 0.000 description 6
- 150000002430 hydrocarbons Chemical class 0.000 description 6
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 6
- 238000007363 ring formation reaction Methods 0.000 description 6
- 150000003432 sterols Chemical class 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229930003799 tocopherol Natural products 0.000 description 6
- 239000011732 tocopherol Substances 0.000 description 6
- 125000002640 tocopherol group Chemical class 0.000 description 6
- 235000019149 tocopherols Nutrition 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 description 6
- 239000008158 vegetable oil Substances 0.000 description 6
- 150000003735 xanthophylls Chemical class 0.000 description 6
- 235000008210 xanthophylls Nutrition 0.000 description 6
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 238000010908 decantation Methods 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 238000000227 grinding Methods 0.000 description 5
- 235000012680 lutein Nutrition 0.000 description 5
- 239000001656 lutein Substances 0.000 description 5
- 229960005375 lutein Drugs 0.000 description 5
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 5
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 5
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 4
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 4
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical group CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 4
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 4
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 4
- 240000003768 Solanum lycopersicum Species 0.000 description 4
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 4
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 4
- 239000003377 acid catalyst Substances 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 230000000433 anti-nutritional effect Effects 0.000 description 4
- 235000013793 astaxanthin Nutrition 0.000 description 4
- 239000001168 astaxanthin Substances 0.000 description 4
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 4
- 229940022405 astaxanthin Drugs 0.000 description 4
- 239000012298 atmosphere Substances 0.000 description 4
- 230000002051 biphasic effect Effects 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 229930004069 diterpene Natural products 0.000 description 4
- 125000000567 diterpene group Chemical group 0.000 description 4
- 125000005456 glyceride group Chemical group 0.000 description 4
- QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical compound CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 description 4
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 4
- 229930003658 monoterpene Natural products 0.000 description 4
- 238000006386 neutralization reaction Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 239000008601 oleoresin Substances 0.000 description 4
- 239000002798 polar solvent Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 229930004725 sesquiterpene Natural products 0.000 description 4
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 4
- 229930003802 tocotrienol Natural products 0.000 description 4
- 239000011731 tocotrienol Substances 0.000 description 4
- 235000019148 tocotrienols Nutrition 0.000 description 4
- 229940068778 tocotrienols Drugs 0.000 description 4
- 235000010930 zeaxanthin Nutrition 0.000 description 4
- 239000001775 zeaxanthin Substances 0.000 description 4
- 229940043269 zeaxanthin Drugs 0.000 description 4
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 3
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 3
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 3
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 3
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000013734 beta-carotene Nutrition 0.000 description 3
- 239000011648 beta-carotene Substances 0.000 description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 3
- 229930006722 beta-pinene Natural products 0.000 description 3
- 229960002747 betacarotene Drugs 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- 229940110767 coenzyme Q10 Drugs 0.000 description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 235000011869 dried fruits Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000021588 free fatty acids Nutrition 0.000 description 3
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 3
- 235000001510 limonene Nutrition 0.000 description 3
- 229940087305 limonene Drugs 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 238000001172 liquid--solid extraction Methods 0.000 description 3
- 235000012661 lycopene Nutrition 0.000 description 3
- 239000001751 lycopene Substances 0.000 description 3
- 229960004999 lycopene Drugs 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 125000002299 monoterpene group Chemical group 0.000 description 3
- 238000005325 percolation Methods 0.000 description 3
- 229940068065 phytosterols Drugs 0.000 description 3
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 2
- CCPPLLJZDQAOHD-GJGKEFFFSA-N (+)-vernolic acid Chemical compound CCCCC[C@H]1O[C@H]1C\C=C/CCCCCCCC(O)=O CCPPLLJZDQAOHD-GJGKEFFFSA-N 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- JSNRRGGBADWTMC-UHFFFAOYSA-N (6E)-7,11-dimethyl-3-methylene-1,6,10-dodecatriene Chemical compound CC(C)=CCCC(C)=CCCC(=C)C=C JSNRRGGBADWTMC-UHFFFAOYSA-N 0.000 description 2
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 2
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 description 2
- IHWPQGIYXJKCOV-PTNGSMBKSA-N (z)-3-hydroxy-1-(4-methoxy-1-benzofuran-5-yl)-3-phenylprop-2-en-1-one Chemical compound C1=CC=2OC=CC=2C(OC)=C1C(=O)\C=C(/O)C1=CC=CC=C1 IHWPQGIYXJKCOV-PTNGSMBKSA-N 0.000 description 2
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 2
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 2
- 229930195730 Aflatoxin Natural products 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 2
- 240000001592 Amaranthus caudatus Species 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 240000005343 Azadirachta indica Species 0.000 description 2
- 239000005878 Azadirachtin Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 244000241235 Citrullus lanatus Species 0.000 description 2
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- 235000009852 Cucurbita pepo Nutrition 0.000 description 2
- OXQKEKGBFMQTML-UHFFFAOYSA-N D-glycero-D-gluco-heptitol Natural products OCC(O)C(O)C(O)C(O)C(O)CO OXQKEKGBFMQTML-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 241000221089 Jatropha Species 0.000 description 2
- 241000219745 Lupinus Species 0.000 description 2
- 235000013500 Melia azadirachta Nutrition 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 108010025020 Nerve Growth Factor Proteins 0.000 description 2
- 102000015336 Nerve Growth Factor Human genes 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- OXQKEKGBFMQTML-WAHCGKIUSA-N Perseitol Natural products OC[C@H](O)[C@H](O)C(O)[C@H](O)[C@H](O)CO OXQKEKGBFMQTML-WAHCGKIUSA-N 0.000 description 2
- 235000004599 Pongamia pinnata Nutrition 0.000 description 2
- 244000037433 Pongamia pinnata Species 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 2
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 244000040738 Sesamum orientale Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000736851 Tagetes Species 0.000 description 2
- 235000012308 Tagetes Nutrition 0.000 description 2
- QHOPXUFELLHKAS-UHFFFAOYSA-N Thespesin Natural products CC(C)c1c(O)c(O)c2C(O)Oc3c(c(C)cc1c23)-c1c2OC(O)c3c(O)c(O)c(C(C)C)c(cc1C)c23 QHOPXUFELLHKAS-UHFFFAOYSA-N 0.000 description 2
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- BLGXFZZNTVWLAY-CCZXDCJGSA-N Yohimbine Natural products C1=CC=C2C(CCN3C[C@@H]4CC[C@@H](O)[C@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-CCZXDCJGSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000005409 aflatoxin Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 239000004178 amaranth Substances 0.000 description 2
- 235000012735 amaranth Nutrition 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- VEHPJKVTJQSSKL-UHFFFAOYSA-N azadirachtin Natural products O1C2(C)C(C3(C=COC3O3)O)CC3C21C1(C)C(O)C(OCC2(OC(C)=O)C(CC3OC(=O)C(C)=CC)OC(C)=O)C2C32COC(C(=O)OC)(O)C12 VEHPJKVTJQSSKL-UHFFFAOYSA-N 0.000 description 2
- FTNJWQUOZFUQQJ-NDAWSKJSSA-N azadirachtin A Chemical compound C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C\C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-NDAWSKJSSA-N 0.000 description 2
- FTNJWQUOZFUQQJ-IRYYUVNJSA-N azadirachtin A Natural products C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C/C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-IRYYUVNJSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- BLGXFZZNTVWLAY-UHFFFAOYSA-N beta-Yohimbin Natural products C1=CC=C2C(CCN3CC4CCC(O)C(C4CC33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-UHFFFAOYSA-N 0.000 description 2
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 230000000853 biopesticidal effect Effects 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001840 cholesterol esters Chemical class 0.000 description 2
- 235000000484 citronellol Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 2
- 229960002061 ergocalciferol Drugs 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000021022 fresh fruits Nutrition 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 229930000755 gossypol Natural products 0.000 description 2
- 229950005277 gossypol Drugs 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- ZQBFAOFFOQMSGJ-UHFFFAOYSA-N hexafluorobenzene Chemical compound FC1=C(F)C(F)=C(F)C(F)=C1F ZQBFAOFFOQMSGJ-UHFFFAOYSA-N 0.000 description 2
- XAOGXQMKWQFZEM-UHFFFAOYSA-N isoamyl propanoate Chemical compound CCC(=O)OCCC(C)C XAOGXQMKWQFZEM-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 239000003350 kerosene Substances 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 150000002630 limonoids Chemical class 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 2
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- 229940053128 nerve growth factor Drugs 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- OXQKEKGBFMQTML-BIVRFLNRSA-N perseitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO OXQKEKGBFMQTML-BIVRFLNRSA-N 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 150000003071 polychlorinated biphenyls Chemical class 0.000 description 2
- IHWPQGIYXJKCOV-UHFFFAOYSA-N pongamol Natural products C1=CC=2OC=CC=2C(OC)=C1C(=O)C=C(O)C1=CC=CC=C1 IHWPQGIYXJKCOV-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- WBHHMMIMDMUBKC-QJWNTBNXSA-N ricinoleic acid Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(O)=O WBHHMMIMDMUBKC-QJWNTBNXSA-N 0.000 description 2
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000000935 solvent evaporation Methods 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- NUMQCACRALPSHD-UHFFFAOYSA-N tert-butyl ethyl ether Chemical compound CCOC(C)(C)C NUMQCACRALPSHD-UHFFFAOYSA-N 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- 229960004559 theobromine Drugs 0.000 description 2
- CGVXVPQJMYMMIH-HKDZDBKOSA-N tigliane Chemical class C1[C@H](C)C[C@H]2[C@@H]3C(C)(C)[C@@H]3C[C@@H](C)[C@@H]2[C@@H]2C[C@H](C)C[C@H]21 CGVXVPQJMYMMIH-HKDZDBKOSA-N 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 235000019871 vegetable fat Nutrition 0.000 description 2
- 235000001892 vitamin D2 Nutrition 0.000 description 2
- 239000011653 vitamin D2 Substances 0.000 description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 2
- 235000005282 vitamin D3 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 229940021056 vitamin d3 Drugs 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 2
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 description 2
- 229960000317 yohimbine Drugs 0.000 description 2
- AADVZSXPNRLYLV-UHFFFAOYSA-N yohimbine carboxylic acid Natural products C1=CC=C2C(CCN3CC4CCC(C(C4CC33)C(O)=O)O)=C3NC2=C1 AADVZSXPNRLYLV-UHFFFAOYSA-N 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- CXENHBSYCFFKJS-UHFFFAOYSA-N (3E,6E)-3,7,11-Trimethyl-1,3,6,10-dodecatetraene Natural products CC(C)=CCCC(C)=CCC=C(C)C=C CXENHBSYCFFKJS-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- QLCJOAMJPCOIDI-UHFFFAOYSA-N 1-(butoxymethoxy)butane Chemical compound CCCCOCOCCCC QLCJOAMJPCOIDI-UHFFFAOYSA-N 0.000 description 1
- OKIDIWHWTIMACU-MNEPGTOVSA-N 12R-HODE Chemical compound CC\C=C/CC[C@@H](O)C\C=C/CCCCCCCC(O)=O OKIDIWHWTIMACU-MNEPGTOVSA-N 0.000 description 1
- HNICUWMFWZBIFP-BSZOFBHHSA-N 13-HODE Chemical compound CCCCCC(O)\C=C\C=C/CCCCCCCC(O)=O HNICUWMFWZBIFP-BSZOFBHHSA-N 0.000 description 1
- HNICUWMFWZBIFP-UHFFFAOYSA-N 13-hydroxyoctadeca-9,11-dienoic acid Chemical compound CCCCCC(O)C=CC=CCCCCCCCC(O)=O HNICUWMFWZBIFP-UHFFFAOYSA-N 0.000 description 1
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 1
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- FBUKMFOXMZRGRB-YFHOEESVSA-N 9(10)-EpOME Chemical compound CCCCC\C=C/CC1OC1CCCCCCCC(O)=O FBUKMFOXMZRGRB-YFHOEESVSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 235000009899 Agrostemma githago Nutrition 0.000 description 1
- 240000000254 Agrostemma githago Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000454552 Astrocaryum murumuru Species 0.000 description 1
- GWEIHUNYMRRZJJ-MOAWTDCJSA-N Auricolic acid Chemical compound CC\C=C/CCC(O)C\C=C/CCCCCCCCCC(O)=O GWEIHUNYMRRZJJ-MOAWTDCJSA-N 0.000 description 1
- GWEIHUNYMRRZJJ-UHFFFAOYSA-N Auricolic acid Natural products CCC=CCCC(O)CC=CCCCCCCCCCC(O)=O GWEIHUNYMRRZJJ-UHFFFAOYSA-N 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241000235553 Blakeslea trispora Species 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- 235000016401 Camelina Nutrition 0.000 description 1
- 244000197813 Camelina sativa Species 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- FBUKMFOXMZRGRB-UHFFFAOYSA-N Coronaric acid Natural products CCCCCC=CCC1OC1CCCCCCCC(O)=O FBUKMFOXMZRGRB-UHFFFAOYSA-N 0.000 description 1
- 241000723382 Corylus Species 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 235000003901 Crambe Nutrition 0.000 description 1
- 241000220246 Crambe <angiosperm> Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 241000219992 Cuphea Species 0.000 description 1
- 240000001689 Cyanthillium cinereum Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- OONXYOAWMIVMCI-UHFFFAOYSA-N D-Lesquerolinsaeure Natural products CCCCCCC(O)CC=CCCCCCCCCCC(O)=O OONXYOAWMIVMCI-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 241001071905 Echium Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 241000532497 Euphorbia lagascae Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000976924 Inca Species 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 240000003450 Mallotus philippensis Species 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 241000040932 Muriellopsis Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 241001542817 Phaffia Species 0.000 description 1
- 241000390166 Physaria Species 0.000 description 1
- 235000011615 Pinus koraiensis Nutrition 0.000 description 1
- 240000007263 Pinus koraiensis Species 0.000 description 1
- 235000004768 Pistacia lentiscus Nutrition 0.000 description 1
- 240000005428 Pistacia lentiscus Species 0.000 description 1
- 229920000175 Pistacia lentiscus Polymers 0.000 description 1
- 241000694540 Pluvialis Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 241001466077 Salina Species 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 235000005318 Serenoa repens Nutrition 0.000 description 1
- 240000006661 Serenoa repens Species 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 230000002528 anti-freeze Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000003225 biodiesel Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000020113 brazil nut Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- BTMVHUNTONAYDX-UHFFFAOYSA-N butyl propionate Chemical compound CCCCOC(=O)CC BTMVHUNTONAYDX-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000003796 chancre Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- JHXAZBBVQSRKJR-UHFFFAOYSA-N coriolic acid Natural products CCCCCC(=O)C=CC=CCCCCCCCC(O)=O JHXAZBBVQSRKJR-UHFFFAOYSA-N 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- WVIIMZNLDWSIRH-UHFFFAOYSA-N cyclohexylcyclohexane Chemical group C1CCCCC1C1CCCCC1 WVIIMZNLDWSIRH-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- DIOQZVSQGTUSAI-NJFSPNSNSA-N decane Chemical compound CCCCCCCCC[14CH3] DIOQZVSQGTUSAI-NJFSPNSNSA-N 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 150000002013 dioxins Chemical class 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000011552 falling film Substances 0.000 description 1
- 229930009668 farnesene Natural products 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 239000009355 kamala Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- OONXYOAWMIVMCI-KWRJMZDGSA-N lesquerolic acid Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCCCC(O)=O OONXYOAWMIVMCI-KWRJMZDGSA-N 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000004890 malting Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- WOFPPJOZXUTRAU-UHFFFAOYSA-N octan-4-ol Chemical compound CCCCC(O)CCC WOFPPJOZXUTRAU-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000011765 phytoene Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000012776 robust process Methods 0.000 description 1
- LMHHRCOWPQNFTF-UHFFFAOYSA-N s-propan-2-yl azepane-1-carbothioate Chemical compound CC(C)SC(=O)N1CCCCCC1 LMHHRCOWPQNFTF-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000000526 short-path distillation Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011949 solid catalyst Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002910 solid waste Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 150000003431 steroids Chemical group 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 238000002411 thermogravimetry Methods 0.000 description 1
- WRCITXQNXAIKLR-UHFFFAOYSA-N tiadenol Chemical compound OCCSCCCCCCCCCCSCCO WRCITXQNXAIKLR-UHFFFAOYSA-N 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 150000003628 tricarboxylic acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- CCPPLLJZDQAOHD-UHFFFAOYSA-N vernolic acid Natural products CCCCCC1OC1CC=CCCCCCCCC(O)=O CCPPLLJZDQAOHD-UHFFFAOYSA-N 0.000 description 1
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/36—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/02—Refining fats or fatty oils by chemical reaction
- C11B3/06—Refining fats or fatty oils by chemical reaction with bases
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B7/00—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils
- C11B7/0008—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of solubilities, e.g. by extraction, by separation from a solution by means of anti-solvents
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B7/00—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils
- C11B7/0008—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of solubilities, e.g. by extraction, by separation from a solution by means of anti-solvents
- C11B7/0041—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of solubilities, e.g. by extraction, by separation from a solution by means of anti-solvents in mixtures of individualized solvents (water is not taken into account)
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
- C11C1/08—Refining
- C11C1/10—Refining by distillation
Definitions
- the present invention relates to the field of oleochemistry. More particularly, the invention relates to a process for extracting unsaponifiables from a renewable lipid raw material, in particular from an oleaginous fruit, in particular avocado, from an oleaginous seed or from an animal raw material, algal, fungal or yeast, or microorganism.
- a renewable lipid raw material in particular from an oleaginous fruit, in particular avocado, from an oleaginous seed or from an animal raw material, algal, fungal or yeast, or microorganism.
- lipids substances of biological origin soluble in non-polar solvents.
- the lipids may be saponifiable (for example triglycerides) or unsaponifiable (for example steroid skeleton molecules).
- unsaponifiable is intended to mean all compounds which, after total saponification of a fatty substance, that is to say under the prolonged action of an alkaline base, remain insoluble in water and can be extracted by a solvent. organic in which they are soluble. Unsaponifiables are usually a minor fraction in fat.
- Renewable lipid raw materials contain very variable proportions of unsaponifiable compounds.
- the contents of unsaponifiable fraction obtained by extraction of different vegetable oils according to various known methods range from 1 to 7% by weight of unsaponifiables in avocado oil, compared with 0.5% in coconut oil and 1% of coconut oil. % in soybean oil or in olive oil.
- the conventional processes for extracting unsaponifiables generally use, as lipid raw material, vegetable oils and their derivatives and co-products derived from the lipid extraction industry (vegetable oils, animal fats, marine oils, vegetable oleoresins) from their refining and their transformation. Most often, it involves extracting unsaponifiables of crude, semi-refined or refined vegetable oils, unsaponifiable concentrates of refined oils obtained by molecular distillation or extraction by supercritical fluids.
- oils deodorization escapements which are abundant co-products of the chemical or physical refining of vegetable oils.
- other lipid-refining co-products may also be acid oils, neutralization pastes, lipids retained by the bleaching earths used to decolorize the oils, and the soils from the winterization units. may also use co-products derived from the trituration of oleaginous or oleaginous fruits such as oilcakes, cockles or seed kernels, molasses, vegetable waters.
- unsaponifiable fractions are produced from industrial co-products such as paper mills, also called tall oil.
- unsaponifiable fractions of co-products derived from beverage industries such as breweries, rum factories, industrial maltings are extracted.
- the unsaponifiable extraction processes most often comprise a step of transesterification or esterification of the fat obtained by pressure, and / or a stage of saponification of the fat followed by a liquid-liquid extraction using an organic solvent.
- the methods of selective extraction of unsaponifiable fractions are few.
- the application WO 201 1/048339 describes a process for extracting an unsaponifiable fraction of a renewable raw material, comprising a) the dehydration and conditioning of the renewable raw material, b) the transesterification by reactive trituration of the raw material.
- lipidic conditioned in the presence of a light alcohol and a catalyst c) the evaporation of the light alcohol, d) the concentration of the liquid phase so as to obtain a concentrate comprising the unsaponifiable fraction diluted in alkyl esters.
- fatty acids e) saponification of the unsaponifiable concentrate, f) extraction of the unsaponifiable fraction of the saponified mixture.
- the avocado because of its high content of unsaponifiable fraction, deserves special attention. It gives access, in a known manner, to particular lipids of furanic type, the main component of which is a linoleic furan denoted H7 of formula:
- furan lipids of avocado is meant according to the invention the components corresponding to the formula: wherein R is a C1-C19 hydrocarbon linear chain, preferably C13-C17 saturated or comprising one or more ethylenic or acetylenic unsaturations.
- R is a C1-C19 hydrocarbon linear chain, preferably C13-C17 saturated or comprising one or more ethylenic or acetylenic unsaturations.
- avocado furan lipids are metabolites of precursor compounds that are initially present in fruit and leaves which, under the effect of heat, dehydrate and cyclize into furan derivatives.
- linoleic furan H7 is derived from the thermal transformation of the following keto-hydroxylated precursor, denoted P1H7:
- the precursor P1 H7 is generally converted to linoleic furan H7 at a temperature ranging from 80 to 120 ° C.
- certain compounds initially present in the fruit and leaves of the avocado may be in the form of polyhydroxy fatty alcohols most often non acetylated, such as the following compound:
- polyhydroxylated avocado fatty alcohol is understood to mean a polyol in the form of a saturated C17-C21 hydrocarbon linear main chain or comprising one or more ethylenic or acetylenic unsaturations, and comprising at least two hydroxyl groups, the groups hydroxyls being generally located on a part of the chain main, preferably to one of the two ends of the main chain, the other part of this main chain thus forming the fatty chain (hydrophobic portion) of the polyol.
- the content of polyhydroxy fatty alcohols in the fruit depends mainly on the climatic conditions, the quality of the soil, the season and the ripening of the fruit when it is harvested.
- the application FR 2678632 describes a process for obtaining the unsaponifiable fraction of avocado from an avocado oil enriched in one of its fractions, called H, corresponding in fact to these same furan lipids.
- the preparation of such an unsaponifiable rich in furanic lipids, the content of which can vary from 30 to 60%, is essentially conditioned by controlled heating of the fresh fruits, previously sliced into thin strips, at a temperature of between 80 and 120 ° C. , and for a period preferably chosen between 24 to 48 hours. This heat treatment makes it possible, after extraction, to obtain an avocado oil rich in furanic lipids.
- obtaining the unsaponifiable fraction is carried out according to a conventional method of saponification, supplemented with a liquid-liquid extraction step with an organic solvent.
- the application WO 01/21605 describes a process for extracting polyhydroxylated furan lipid and fatty alcohol compounds from avocado, comprising the heat treatment of the fruit at a temperature of at least 80 ° C. (controlled drying), the extraction of oil by cold pressing, enrichment in unsaponifiable by crystallization by cold or liquid-liquid extraction or molecular distillation, saponification by ethanolic potash, extraction of the unsaponifiable in a column against the current by a organic solvent, followed by filtration steps, washing, desolvation, deodorization and final molecular distillation.
- This process makes it possible to obtain either a distillate comprising mainly furanic lipids of avocado, or a distillate comprising mainly furanic lipids and polyhydroxy fatty alcohols of avocado. However, this process makes it possible to value only a small portion of the fruit.
- Another disadvantage of the process lies in the production of a meal unsuitable for animal feed.
- the latter indeed contains antinutritional compounds (precursors H toxic and biopesticide activity, furanic lipids) and highly degraded proteins during extraction by mechanical pressure of air-dried fruits (in fact highly oxidized), poor digestibility proteins . Therefore, the meal or its proteins, can not be valued in animal feed and even less human even though the fruit pulp is commonly consumed by man (guacamole, fruit of mouth).
- the noble polysaccharides of the fruit such as perseitol and nanoheptulose, unique sugars of the vegetable kingdom, with proven pharmaceutical, cosmetic and nutritional properties (eg liver comfort), are partly destroyed by the Maillard reactions and / or caramelization induced by the mechanical pressure of dehydrated fruits, or made very difficult to extract because too strong interaction with the fibrous matrix and protein.
- this type of process allows only a minor valuation of the fruit that can be estimated less than 15%.
- the subject of the invention is a process for extracting an unsaponifiable fraction from a renewable raw material containing lipids functionalized by one or more functions chosen from hydroxyl, epoxide, ketone, thiol, aldehyde, ether and amine functions, comprising the following steps:
- the invention further relates to a method for extracting an unsaponifiable fraction from a renewable raw material comprising the following steps:
- the renewable raw material optionally undergoing heat treatment at a temperature greater than or equal to 75 ° C, preferably greater than or equal to 80 ° C, before or during step b), preferably before step a), during step a) or between step a) and step b).
- the two processes of the invention differ in that the first process aims to recover an unsaponifiable fraction soluble in an alcoholic polar phase (or whose precursors are soluble in such a phase), while the second process aims to recover the unsaponifiable fraction. soluble in an apolar organic phase (or whose metabolites are soluble in such a phase).
- the raw materials are not heated initially at a high temperature in the first process (they are only after the reactive trituration step), whereas they are heated before reactive trituration step in the second method, so as to reveal the characteristic furan compounds of the heat-treated avocado earlier.
- the reactive trituration step is carried out with avocados which have not undergone such a heat treatment, these containing at this stage furan lipid precursors.
- the invention therefore relates to a process for extracting an unsaponifiable fraction of a lipidic renewable raw material, generally vegetable or animal, preferably plant.
- This raw material can be chosen in particular from oleaginous fruits, oilseeds, oilseed seeds, seed shells, oleaginous almonds, sprouts, fruit cuticles and nuclei, animal raw materials, algal, fungal or yeast of lipid-rich microorganisms.
- the raw material used is an oleaginous fruit, which may be, without limitation, olive, shea, amaranth, palm, buritti, tucuman, squash, serenoa repens, the African palm or the avocado.
- the raw material is a seed, an almond, a seed, a cuticle or a core of a vegetable raw material chosen from rapeseed, soya, sunflower, cotton, wheat, maize , rice, grapes (pips), walnuts, hazelnuts, jojoba, lupine, camelina, flax, copra, safflower, crambe, copra, peanut, jatropha, castor, neem, chancre, cuphea, lesquerella, inca inchi, perilla, echium, evening primrose, borage, blackcurrant, Korean pine, Chinese wood, cotton, poppy ( seeds), sesame, amaranth, coffee, oats, tomatoes, lentisks, marigolds, karanja, rice bran, Brazil nuts, andiroba, schizandra, ucuhuba, cupuacu, murumuru, piqui, lemon seeds, tangerine, orange, watermelon, watermel
- the lipidic raw material may also be an animal raw material, an algae, a mushroom, a yeast or a mold.
- animal raw materials we prefer the liver and the skin of fish, especially those of shark, cod and chimera, as well as the solid waste of the meat industry (brains, tendons, lanolin ...) .
- Other vegetable raw materials containing oleoresins rich in unsaponifiable are tomato, tagetes, paprika, rosemary.
- Examples of algae containing unsaponifiable compounds of interest are microalgae Duniella salina (rich in beta-carotene) and Hematococcus pluvialis (rich in asthaxanthin).
- Examples of microorganisms, especially bacteria containing unsaponifiable compounds of interest are mycelia or any other mold and fungus (ergosterol production), Phaffia sp. (producing asthaxanthine), Blakeslea trispora, (producing lycopene and phytoene), Muriellopsis sp.
- the raw materials used in the process according to the invention have an acidity level of less than 3 mg KOH / g.
- higher levels of free fatty acids in these raw materials lead to the formation of soaps in a basic medium.
- fatty acids is understood to mean saturated, monounsaturated or polyunsaturated, linear or branched, cyclic or acyclic C4-C28 aliphatic mono-, di- or tricarboxylic acids which may comprise particular organic functions (hydroxyl , epoxides, ).
- the raw materials used in the first method of the invention contain lipid constituents functionalized by one or more polar functions, chosen from hydroxyl, epoxide, ketone, thiol, aldehyde, ether and amine functions, such as, for example, avocado. , karanja, jatropha, andiroba, neem, schizandra, lupine shell, cashew, sesame, rice bran, cotton, or raw materials leading to oils rich in phytosterols such as corn, soybean, sunflower, rapeseed, all of which are very rich in such compounds.
- polar functions chosen from hydroxyl, epoxide, ketone, thiol, aldehyde, ether and amine functions, such as, for example, avocado. , karanja, jatropha, andiroba, neem, schizandra, lupine shell, cashew, sesame, rice bran, cotton, or raw materials leading to oils rich in phyto
- These raw materials can be raw materials that are fresh or have undergone prior transformations, for example a first fat extraction step such as pressure or centrifugation.
- a first fat extraction step such as pressure or centrifugation.
- avocado milks obtained by pressing pulps the products of settling partially deoiled pulps by centrifugation, by-products generally present at the output of the centrifugal strainers, the centrifuge pellets produced in separation, avocado cakes, co-produced during the cold pressing of fruits (fresh or dried) or the liquid-solid extraction of avocado oil from fresh or dried fruit, using an organic solvent, the kernels and avocado leaves.
- This method comprises a first step a) dehydration and optionally conditioning the renewable raw material.
- Dehydration and conditioning when carried out at a temperature of less than or equal to 80 ° C, preferably less than or equal to 75 ° C, are said to be controlled (this is mandatory in the case of avocado).
- Said temperature is preferably greater than or equal to -50 ° C.
- the temperature ranges from 50 to 120 ° C, more preferably from 75 to 120 ° C.
- Dehydration can be carried out under an inert atmosphere, in particular in the case of raw materials containing fragile compounds that can oxidize during a rise in temperature. It is preferably carried out under atmospheric pressure.
- Dehydration can be performed before or after conditioning (when it occurs).
- oleaginous fruits such as avocado are dehydrated before being packaged, while conversely oleaginous seeds are first packaged before dehydration.
- Dehydration is understood to mean all the techniques known to those skilled in the art which allow the total or partial elimination of the water of the raw material. These techniques include, but are not limited to, fluidized bed drying, drying under hot air or inert atmosphere (eg, nitrogen), fixed bed, atmospheric pressure or vacuum, as a thick layer or thin layer, in a continuous belt dryer or hot air rotary, but also microwave drying, spray drying, lyophilization and osmotic dehydration in solution (direct osmosis) or solid phase (eg drying in osmotic bags), drying with solid absorbents such as zeolites or molecular sieves.
- fluidized bed drying drying under hot air or inert atmosphere (eg, nitrogen), fixed bed, atmospheric pressure or vacuum, as a thick layer or thin layer, in a continuous belt dryer or hot air rotary, but also microwave drying, spray drying, lyophilization and osmotic dehydration in solution (direct osmosis) or solid phase (eg drying in osmotic bags), drying
- the drying time and the temperature are chosen so that the residual moisture is less than or equal to 3% by weight, preferably less than or equal to 2%, relative to the mass of the lipidic raw material. obtained at the end of the dehydration step.
- the residual moisture of the raw material can be determined by thermogravimetry. This drying step is important so that the subsequent transesterification step takes place under the best conditions. It will make the extraction of the lipid constituents more efficient, in particular because it causes the cells of the raw material to burst, as well as the breakage of the oil-in-water emulsion as it is present in this raw material. It can further facilitate the conditioning of the raw material, especially crushing or crushing operations, which will make solvent extraction more efficient due to a gain in the area of contact with the solvents.
- thermoregulated in a thin layer and under a stream of hot air is preferred.
- the temperature is preferably between 70 and 75 ° C, and the dehydration preferably lasts from 8 to 36 hours.
- the objective of the optional conditioning of the raw material is to make the fats as accessible as possible to extraction solvents and catalysts, especially according to a simple phenomenon of percolation.
- Packaging can also increase the surface area and porosity of the raw material in contact with these reagents. The conditioning of the raw material does not lead to any extraction of fat.
- the renewable raw material is conditioned by flattening, flaking, blowing or grinding in powder form.
- the raw material can be toasted or flaked, or conditioned and / or dried by freeze-drying, per- evaporation, atomization, mechanical grinding, cryogrinding, skinning, flash-relaxation (fast drying by vacuum and decompression rapid), conditioned by pulsed electromagnetic fields, by reactive extrusion or not, flattening by means of a mechanical flattener with smooth or corrugated rollers, blowing by introduction of hot air or superheated steam.
- avocado mainly cut avocado fruit will be used, then subjected to the controlled dehydration step, and finally the dried fruit will be conditioned, usually by grinding the fresh pulp.
- the raw material undergoes a step b) of reactive trituration in the presence of at least one polar organic solvent comprising at least one light alcohol, at least one apolar cosolvent immiscible with said light alcohol (in the conditions of the reactive trituration operation) and at least one catalyst.
- at least one polar organic solvent comprising at least one light alcohol, at least one apolar cosolvent immiscible with said light alcohol (in the conditions of the reactive trituration operation) and at least one catalyst.
- reactive trituration any operation to transform saponifiable lipids (or fat) (especially triglycerides) into alkyl esters of fatty acids (generally alkyl monoesters of fatty acids) and glycerol, preferably in the presence of one or more reactive elements.
- the trituration is carried out in the presence of a light alcohol, an apolar cosolvent and a catalyst.
- anhydrous solvents and cosolvents and preferably solvents having a boiling point low enough to be distilled, will be used.
- water may be added to the binary mixture of solvents in order, in particular, to extract, with greater efficiency, the highly polar compounds, in particular the hydroxylated ones, the quantity of water involved being preferably 0.1. at 20% by weight of the solvent mixture, preferably from 0.5 to 5%.
- This step makes it possible on the one hand to extract the fats, in particular the oil from the dehydrated raw material and at the same time to transesterify it, and on the other hand to isolate a fraction enriched in polar lipid constituents, containing a or several functions chosen from the hydroxyl (preferably aliphatic), epoxide, ketone, thiol, aldehyde, ether and amine (free) functions, unsaponifiable or not, and a fraction enriched in constituents low or non-polar lipids, in particular constituents containing no hydroxyl, epoxide, ketone, thiol, aldehyde, ether and amine functions.
- an apolar cosolvent promotes the obtaining of a heterogeneous medium and two lipid phases whose constitutions will be very different.
- the lipid constituents which are not functionalized by one or more hydroxyl, epoxide, ketone, thiol, aldehyde, ether and amine functions will be found preferentially in the apolar phase, whereas the lipid constituents functionalized by one or more hydroxyl functions, epoxide ketone, thiol, aldehyde, ether or amine will be found preferentially in the polar phase (light alcohol).
- This step allows the selective extraction of functionalized lipid components by one or more hydroxyl (preferably aliphatic), epoxide, ketone, thiol, aldehyde, ether or amine (unsaponifiable or non-unsaponifiable) functions, preferably several, which are separated from the mixture of lipid constituents (especially fatty acid esters) having no such functions, present in the medium at the end of the transesterification reaction.
- hydroxyl preferably aliphatic
- epoxide epoxide
- ketone ketone
- thiol aldehyde
- ether or amine unsaponifiable or non-unsaponifiable
- these functionalized lipid components may be, without limitation, polyhydroxy fatty alcohols and keto-hydroxyl compounds furan lipid precursors (especially the compound P1 H7 mentioned above, precursor of linolenic furan H7) which are present in the avocado, non-esterified sterols, or esters of the following fatty acids: ricinoleic acid (12-hydroxy cis 9-octadecenoic acid) present in particular in castor oil, lesquerolic acid (acid 14- 11-hydroxy-1-eicosanoic acid), densipolic acid (12-hydroxy-9,15-octadecadienoic acid) and auricolic acid (14-hydroxy-1,1,17-eicosadienoic acid), all of which are present especially in genus Lesquerrella, coriolic acid (13-hydroxy-9,1 1 -octadecadienoic acid), kamlolenic acid (18-hydroxy-9,1 1, 13-octade
- Step b) is carried out under conditions of temperature, stirring and duration sufficient to allow the extraction of triglycerides and other lipid constituents from the raw material and the transesterification of said triglycerides, leading to the obtaining of a mixture comprising in particular fatty acid esters, glycerol, the native unsaponifiable fraction (not modified by this step), and according to the type of raw material used, soluble polysaccharides, phenolic compounds, glucosinolates, isocyanates, polar alkaloids, polar terpenes, glycerol and a cake.
- Step b) is, however, carried out at a temperature of less than or equal to 80 ° C., preferably less than or equal to 75 ° C. in the case of avocado in particular, this temperature control avoiding the conversion of furan lipid precursors. in furanic lipids. These therefore remain present in their hydroxylated form (not cyclized to furans) during the reactive trituration.
- step b) can be carried out without temperature limitation, i.e., the temperature may exceed 75 or 80 ° C.
- step b) can be carried out by carrying out heating at a temperature ranging from 40 to 100 ° C.
- Step b) is generally carried out at room temperature but can also be carried out by carrying out heating, at a temperature preferably of at least 40 ° C and preferably of less than or equal to 80 ° C, preferably lower or equal to 75 ° C.
- light alcohol an alcohol (comprising one or more hydroxyl functional groups) whose molecular mass is less than or equal to 150 g / mol, linear or branched, preferably C -C 6, more preferably C 1 -C 4 .
- the light alcohol is a monoalcohol. It is preferably an aliphatic alcohol and ideally an aliphatic monoalcohol, preferably selected from methanol, ethanol, n-propanol, isopropanol, n-butanol, n-pentanol, n-hexanol, ethyl-2-hexanol and their isomers.
- methanol n-propanol
- n-pentanol n-hexanol
- ethyl-2-hexanol ethyl-2-hexanol and their isomers.
- the apolar cosolvent immiscible with the light alcohol (under the conditions of the reactive trituration operation), is preferably chosen so that the lipid constituents functionalized by one or more hydroxyl functions, epoxide, ketone, thiol, aldehyde , ether or amine that it is desired to extract are not soluble in this cosolvent. Given their chemical nature, these functionalized lipid components will necessarily have more affinity with the light alcohol phase than with the apolar solvent phase in which they are little (preferably not) soluble.
- the apolar cosolvent is an organic solvent which may especially be hexane, heptane, benzene, bicyclohexyl, cyclohexane, paraffinic alkanes of plant origin obtained by dehydration of natural alcohols (or their Guerbet counterparts) or by hydrotreatment of lipids or biomasses (hydroliquefaction process) or by decarboxylation of fatty acids, decalin, decane, kerosene, kerdane (hydrocarbon fuel fraction heavier than hexane), gas oil, kerosene, methylcyclohexane, tetradecane, supercritical C0 2 , propane or butane pressurized, natural apolar solvents such as terpenes (limonene, alpha and beta pinene, etc.). It is preferably an alkane or a mixture of alkanes, preferably hexane.
- the catalyst is preferably a basic catalyst preferably chosen from alcoholic sodium hydroxide, solid sodium hydroxide, alcoholic potassium hydroxide, solid potassium hydroxide, alkali alcoholates such as methylate, ethylate, n-propylate, isopropylate, n-butylate, lithium i-butylate or t-butylate, sodium or potassium, amines and polyamines, or an acid catalyst preferably selected from sulfuric acid, nitric acid, acid paratoluenesulphonic acid, hydrochloric acid and Lewis acids.
- An acid catalyst will be more particularly used in extreme cases where the free acidity of the fat will be greater than 4 mg KOH / g. This step will lead to the esterification of the free fatty acids, the continuation of the process of continuing the reactive trituration by a base catalyzed transesterification reaction.
- Step b) can be carried out in particular in a stirred bed batch reactor or in a continuous continuous conveyor type continuous extractor reactor.
- the organic solvent and the apolar cosolvent are introduced in countercurrent to one another in a reactor.
- the extraction / trituration can be repeated several times by implementing for example several cascading reactors and intermediate withdrawals, as described in the application WO 2010/084276.
- the reactive trituration step makes it possible to recover (especially after filtration and washing of the cake with a solvent such as a light alcohol) on the one hand two immiscible lipid liquid phases, glycerol and on the other hand a solvent cake.
- a solvent such as a light alcohol
- the resulting mixture of the transesterification step comprises low levels of mono, di or triglycerides. All of these glycerides generally represent less than 3% by weight of the total mass of the mixture, preferably less than 1%.
- the solvent cake resulting from the process of the invention can be dried and then directly used, in particular in animal feed, since it does not contain, or at least very little, antinutritional compounds following the reactive trituration step, in contrast to prior methods which involve a mechanical pressure step.
- the polar phase (alcoholic) in which are soluble especially lipids containing one or more functions selected from the hydroxyl, epoxide, ketone, thiol, aldehyde, ether and amine functions such as polyhydroxy fatty alcohols and furan lipid precursors (in the case of the lawyer) is separated from the apolar phase.
- Said polar phase also contains, in particular, fatty acid esters. The separation of the various fractions can be done in different ways, in particular by centrifugation, decantation and / or distillation.
- apolar solvent phase can be subjected to a solvent evaporation step carried out under a suitable vacuum and temperature.
- the vaporized solvent is then condensed to to be recycled.
- the apolar heavy phase (phase A) consisting mainly of alkyl esters and unsaponifiable (or non-apolar) compounds, can then be used for molecular distillation in order to obtain, on the one hand, purified esters (in the distillate) and on the other hand, a distillation residue enriched in apolar minor compounds.
- phase A consisting mainly of alkyl esters and unsaponifiable (or non-apolar) compounds, can then be used for molecular distillation in order to obtain, on the one hand, purified esters (in the distillate) and on the other hand, a distillation residue enriched in apolar minor compounds.
- the extraction of these mainly unsaponifiable compounds is carried out according to the methods known to those skilled in the art.
- Another variant consists of directly saponifying phase A and extracting the mainly apolar unsaponifiable compounds by (1) liquid-liquid extraction enabling the unsaponifiable compounds to be separated from the soaps, (2) desolvation of the solvent phase enriched in unsaponifiables and (3) final purification of unsaponifiable.
- the light alcohol (polar solvent) is evaporated from the polar phase, in particular under reduced pressure.
- the evaporation temperature is high (especially of the order of 80 ° C or more), it may occur from this stage cyclization of furan lipid precursors into furan lipids.
- the lipid product obtained may undergo a neutralization step (before or after the evaporation of the light alcohol, preferably before), preferably with an acid, then a decantation or centrifugation step which makes it possible to recover residual glycerol from a part and a lipid phase on the other hand, and / or a filtration step.
- the remaining lipid phase can then be washed with water and dried under vacuum.
- the resulting lipid phase (phase containing typically alkyl esters and enriched in unsaponifiable (or not) polar compounds) is then subjected to a step c) of concentration to obtain a mixture enriched in unsaponifiable fraction and optionally heat treatment at a temperature greater than or equal to at 75 ° C, preferably greater than or equal to 80 ° C.
- concentration can be implemented before or after the heat treatment, if it takes place, or these two steps can be carried out concomitantly, if the concentration involves heating to a suitable temperature. As a preference, the concentration is carried out before carrying out the heat treatment.
- the prior concentration of the unsaponifiable oil makes it possible to reduce the quantity of material involved during the possible subsequent saponification step, and thus to extract.
- the concentration step c) can in particular be carried out by liquid-liquid extraction, distillation or by crystallization, in particular crystallization by cold or crystallization by evaporation under vacuum.
- distillation is meant any technique known to those skilled in the art in particular, molecular distillation, distillation at atmospheric pressure or vacuum, multi-stage in series (in particular in a scraped or falling film evaporator), distillation azeotropic, hydrodistillation, steam distillation, deodorization in particular in a layer-thin deodorizer operating under vacuum with or without injection of steam or an inert gas (nitrogen, carbon dioxide).
- the preferred technique is molecular distillation, term by which is meant fractional distillation under high vacuum at high temperature but with a very short contact time, which avoids or limits the denaturation of heat-sensitive molecules.
- This molecular distillation step is carried out using a short-path distillation unit, preferably a device chosen from centrifugal-type molecular distillers. and molecular devices of scraped film type.
- EP-0 493 144 discloses such a molecular distiller.
- the product to be distilled is spread in a thin layer on the heated surface (hot surface) of a conical rotor rotating at high speed.
- the distillation chamber is placed under vacuum. Under these conditions, there is evaporation and not boiling, from the hot surface of the constituents of the unsaponifiable, the advantage being that these fragile products are not degraded during evaporation.
- Scraped film type molecular stills also known to those skilled in the art, include a distillation chamber with a rotating scraper, which allows continuous spreading on the evaporation surface (hot surface) of the product to be distilled. .
- the product vapors are condensed through a refrigerated finger placed in the center of the distillation chamber.
- Peripheral supply and vacuum systems are very similar to those of a centrifugal distiller (feed pumps, vane vacuum pumps and oil diffusion pumps, etc.). The recovery of residues and distillates in glass balloons is by gravitational flow.
- the molecular distillation is preferably carried out at a temperature ranging from 100 to
- the unsaponifiable concentration of the distillate can reach 60% by weight.
- some furan lipid precursors can be cyclized to furan lipids at this stage. This phenomenon, however, remains marginal. It is also possible to resort to conventional distillation which, in the case of avocado, would allow complete cyclization of furan lipid precursors via heating at 75 ° C or higher, preferably at 80 ° C or higher. .
- Distillation generally makes it possible to obtain a light fraction (first distillate) comprising esters (typically alkyl) of high purity fatty acids separated from the unsaponifiable fraction, and at least one heavier fraction (second distillate or residue), comprising the unsaponifiable fraction diluted in (typically alkyl) esters of residual fatty acids.
- first distillate comprising esters (typically alkyl) of high purity fatty acids separated from the unsaponifiable fraction
- second distillate or residue comprising the unsaponifiable fraction diluted in (typically alkyl) esters of residual fatty acids.
- the fraction containing high purity fatty acid esters that is to say generally clear and colorless esters preferably having an ester content greater than 98% by weight and an unsaponifiables content preferably less than 1% , better than 0.1% by weight, can be used directly, especially in cosmetics or pharmacy. If the purity of the ester fraction obtained at the end of the concentration step is insufficient, this fraction can be refined to improve its purity, in particular by molecular distillation.
- the concentrate enriched in unsaponifiable fraction (and depleted in fatty acid esters) contains at this stage precursors of furanic lipids (not very volatile) and / or furanic lipids (which are less volatile than monoesters of fatty acids), if the heat treatment step which will now be described has taken place before or during the concentration step.
- the heat treatment step at 75-80 ° C or more of the lipid phase having or not already been concentrated is mandatory. It is intended to achieve the cyclization of furan lipid precursors into furan lipids.
- This step can be carried out before or after the saponification step (if it takes place), preferably before, otherwise the saponification would transform the furan lipid precursors into modified unsaponifiable derivatives (i.e. other than furan compounds), which are of less interest.
- the duration of this treatment is usually 0.5 to 5 hours, depending on the heating method used.
- the temperature employed for the treatment is generally less than or equal to 150 ° C, preferably less than or equal to 120 ° C. It is of course understood that the temperature and the reaction time are two parameters related to each other as to the expected result of the heat treatment which is to promote the cyclization of furan lipid precursors.
- this heat treatment is carried out under an inert atmosphere, in particular under a continuous stream of nitrogen. It is preferably carried out under atmospheric pressure.
- the heat treatment step may be carried out in the presence or absence of an acid catalyst.
- acid catalyst means the so-called homogeneous inorganic and organic catalysts such as hydrochloric, sulfuric, acetic or para-toluenesulphonic acids, but also, and preferably, heterogeneous solid catalysts such as silica, alumina, silica-aluminas, zirconias. , zeolites, acid resins.
- acidic aluminas with large specific surface areas, ie at least equal to 200 m 2 / g, will be chosen.
- the catalysts of the acidic alumina type are preferred for carrying out the process of the invention.
- the concentrate that has optionally undergone the heat treatment can then be subjected to steps d) saponification of the mixture enriched in unsaponifiable fraction and e) extraction of the unsaponifiable fraction of the saponified mixture, depending on the type of raw material used.
- steps d) and e) are carried out in order to separate the glycerides.
- steps d) and e) it is possible not to perform steps d) and e) and to isolate an oil containing the unsaponifiable fraction accompanied by other compounds such as (mono) esters of fatty acids.
- Saponification is a chemical reaction transforming an ester into a water-soluble carboxylate ion and alcohol.
- the saponification converts in particular the fatty acid esters to fatty acids and to alcohol, the liberated alcohol being mainly the light alcohol used during the reactive trituration step to carry out the transesterification.
- the saponification step may be carried out in the presence of potassium hydroxide or sodium hydroxide in an alcoholic medium, preferably an ethanolic medium.
- Typical experimental conditions are a reaction in the presence of 12N potassium hydroxide under reflux of ethanol for 4 hours.
- a cosolvent may be advantageously used to improve in particular the kinetics of the reaction or to protect the unsaponifiable compounds sensitive to basic pH.
- This cosolvent may especially be selected from terpenes (limonene, alpha and beta pinene, etc.), alkanes, especially paraffins.
- the unsaponifiable fraction of the saponified mixture is then extracted one or more times.
- this step is carried out by liquid-liquid extraction using at least one appropriate organic solvent, that is to say immiscible with the alcoholic or hydroalcoholic solution resulting from the saponification. It makes it possible to separate the salts of fatty acids (soaps) formed during the saponification of the unsaponifiable fraction.
- the organic solvent may in particular be an organic synthesis solvent chosen from optionally halogenated alkanes (especially petroleum ether or dichloromethane), aromatic solvents (especially trifluorotoluene, hexafluorobenzene), haloalkanes, ethers (especially diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tetrahydrofuran, 2-ethoxy-2-methylpropane), ketones (in particular methyl isobutyl ketone, 2-heptanone), propionates (especially ethyl propionate, n-butyl propionate, isoamyl propionate), hexamethyldisiloxane, tetramethylsilane, diacetone alcohol, 1-butoxymethoxy butane, 3-methoxy-3-methyl-1-butanol (MMB) or a organic solvent of natural origin selected from terpenes such as limon
- a terpene Preferably one will choose a terpene.
- the extraction can be performed on a co- or countercurrent extraction column or using a battery of mixer settlers, extractors-columns or centrifugal extractors.
- a continuous liquid-liquid extraction apparatus such as a pulsed column, a settling mixer or the like.
- the unsaponifiable fraction is preferably purified, in particular by centrifugation (removal of soaps), desolvation, washing, drying, filtration and / or deodorization under vacuum. More specifically, the purification step may in particular be carried out by implementing one or more of the following substeps:
- any contaminant remaining including the extraction solvent, pesticides, polycyclic aromatic hydrocarbons.
- the first process according to the invention makes it possible to obtain an unsaponifiable fraction of high purity enriched in polar compounds (with the notable exception, in the case of avocado, of furan lipids, because these, of a slightly polar nature, are present in the unsaponifiable fraction isolated by the first method of the invention because they were formed in situ from polar precursors after the step of selective extraction of the polar compounds).
- the unsaponifiable compounds obtained after the implementation of this process in the finally isolated fraction may be, depending on the nature of the raw material used, the optionally polyhydroxylated fatty alcohols, the furan lipids (in the case of avocado), non-esterified (free) or non-glycosylated sterols and triterpene alcohols, free and glycosylated polyphenols, free or sulphated cholesterol, lignans, phorbols esters, triterpene acids (eg ursolic acid), polar terpenes (mono, di and sesquiterpenes, with alcohol function), free alkaloids, polycosanols, limonoids, xanthophylls (lutein, astaxanthin, zeaxanthin), gossypol, karanjine, shizandrin, azadirachtin, coenzyme Q10, aflatoxins, especially B1 and B2, isoflavones, caffeine
- the average composition of an unsaponifiable avocado obtained as a result of these different steps is as follows, in percentages by weight relative to the total mass of the product. unsaponifiable:
- the unsaponifiable product obtained as described can then be subjected to a (second) distillation stage in order to further improve its purity, preferably a molecular distillation, preferably carried out at a temperature ranging from 100 to 160 ° C. preferably from 100 to 140 ° C, preferably from 10 3 to 5 ⁇ 10 -2 mm Hg.
- the temperature employed varies from 130 to 160 ° C.
- this (second) distillation can make it possible to obtain a distillate comprising, in the case of the avocado, avocado furan lipids, the purity of which may exceed 90% by weight, when the distillation temperature varies from 100.degree. at 140 ° C.
- a distillate comprising predominantly avocado furan lipids and to a lesser extent polyhydroxy avocado fatty alcohols, the combined content of which can exceed 90% by weight, is generally obtained.
- This first method of the invention thus makes it possible to obtain a selective extraction not only of the furan lipids of avocado, but also of the polyhydric fatty alcohols of avocado if they are desired.
- the unsaponifiable compounds obtained at the end of the implementation of this process in the fraction isolated from the apolar solvent phase, in fine may be, according to the nature of the raw material used, the sterol esters, esterified triterpene alcohols, cholesterol esters, tocopherols (and corresponding tocotrienols), sesamolin, sesamin, sterenes, squalene, paraffinic hydrocarbons, terpeno-polar to apolar terpenes (aldehyde-functional mono, di and sesquiterpenes); and / or ketone), esterified xanthophylls (lutein, astaxanthin, zeaxanthin), carotenoid pigments (beta-carotene, lycopene), waxes, calciferol, cholecalciferol, pongamol.
- the renewable raw materials used in the second process of the invention are not particularly limited and optionally contain lipid constituents functionalized with one or more hydroxyl, epoxide, ketone, thiol, aldehyde, ether or amine functions. They necessarily contain lipid constituents which are not functionalized by any of the aforementioned functions (or at least by few of these functions), these being the most common in nature.
- This method comprises a first step a) dehydration and optionally conditioning the renewable raw material.
- Dehydration and conditioning are not necessarily performed at a temperature of less than or equal to 80 ° C or 75 ° C. Said temperature is preferably greater than or equal to -50 ° C. When heating is involved, the temperature generally varies from 50 to 120 ° C., more preferably from 75 to 120 ° C.
- dehydration can be carried out before or after conditioning (when it occurs). It lasts preferably from 8 to 36 hours.
- the renewable raw material optionally undergoes (in the case of avocado in particular) a heat treatment as described in particular in the patent application FR 2678632, at a temperature greater than or equal to 75 ° C, preferably greater than or equal to 80 ° C, before or during step b), preferably before step a), during step a) or between step a) and step b) of reactive trituration.
- a heat treatment as described in particular in the patent application FR 2678632
- the heat treatment and the dehydration of the raw material take place simultaneously and constitute one and the same step.
- this step of heat treatment at 75 ° C or more of the raw material whether or not already conditioned and / or dehydrated is mandatory.
- it is intended to promote the cyclization of furan lipid precursors into furan lipids.
- the duration of this treatment is usually 8 to 36 hours, depending on the heating method used.
- the temperature employed for the treatment is generally less than or equal to 150 ° C, preferably less than or equal to 120 ° C.
- this heat treatment is carried out under an inert atmosphere, in particular under a continuous stream of nitrogen. It is preferably carried out under atmospheric pressure.
- the raw material undergoes a step b) of reactive trituration in the presence of at least one polar organic solvent comprising at least one light alcohol, at least one apolar cosolvent immiscible with said light alcohol and d at least one catalyst.
- these solvents and cosolvents can be anhydrous or not, water can be added to the extraction solvent mixture.
- This step makes it possible on the one hand to extract the fats, in particular the oil from the dehydrated raw material and at the same time to transesterify it, and on the other hand to isolate a fraction enriched in lipid constituents containing (or little) no hydroxyl, epoxide, ketone, thiol, aldehyde, ether and amine functions, and a fraction enriched in polar lipid constituents, in particular functionalized by one or more hydroxyl functions (preferably aliphatic), epoxide, ketone, thiol, aldehyde, ether or amine.
- hydroxyl functions preferably aliphatic
- an apolar cosolvent promotes the obtaining of a heterogeneous medium and two lipid phases whose constitutions will be very different.
- the lipid constituents which are not functionalized by one or more hydroxyl, epoxide, ketone, thiol, aldehyde, ether or amine functions will be found preferentially in the apolar phase, while the most polar lipid constituents, in particular those functionalized by a or several hydroxyl functions, epoxide, ketone, thiol, aldehyde, ether and amine, will be found preferentially in the polar phase (light alcohol).
- This step allows the selective extraction of lipid constituents that are little or not polar (unsaponifiable or not), which are not functionalized by any of the hydroxyl functions, epoxide, ketone, thiol, aldehyde, ether and amine (or at least a few of these functions), which are separated from the mixture of lipid constituents comprising one or more of these functions, preferably several (for example the polyols), present in the medium following the transesterification reaction.
- these non-polar or little polar lipid constituents may be, without limitation, fatty acid esters containing no hydroxyl, epoxide, ketone, thiol, aldehyde, ether and amine functions, furan lipids ( in the case of avocado, furan lipid precursors have already been converted to furanic lipids before the beginning of the reactive trituration step, these furanic lipids being non-hydroxylated), weakly polar alcohols such as tocopherols, squalene , xanthophylls and ester sterols.
- Step b) is carried out under conditions of temperature, stirring and duration sufficient to allow the extraction of triglycerides and other lipid constituents from the raw material and the transesterification of said triglycerides, leading to the obtaining of a mixture comprising in particular fatty acid esters, glycerol, the native unsaponifiable fraction (not modified by this step) and a cake.
- This step b) unlike that of the first process, is carried out without limitation as to the temperature, that is to say that it can exceed 75 or 80 ° C in all cases.
- Step b) is generally carried out at room temperature but can also be carried out by carrying out heating at a temperature ranging from 40 to 100 ° C.
- the apolar cosolvent, immiscible with the light alcohol is preferably chosen such that the lipid constituents functionalized with one or more hydroxyl, epoxide, ketone, thiol, aldehyde, ether or amine which one does not wish to extract are not soluble in this cosolvent. Given their chemical nature, these functionalized lipid components will necessarily have more affinity with the light alcohol phase than with the apolar solvent phase in which they are little (preferably not) soluble.
- the reactive trituration step makes it possible to recover (especially after filtration and washing of the cake with a solvent such as a light alcohol) on the one hand two immiscible lipid liquid phases, glycerol and on the other hand a solvent cake.
- the polar phase (alcoholic phase A) in which the lipids functionalized with hydroxyl groups (preferably aliphatic) and / or epoxide groups such as polyhydroxy fatty alcohols are soluble is separated from the apolar phase.
- said apolar phase contains a high proportion of fatty acid esters.
- the separation of the various fractions can be done in different ways, in particular by centrifugation, decantation and / or distillation.
- the polar solvent phase can be subjected to a solvent evaporation step carried out under a suitable vacuum and temperature.
- the vaporized solvent is then condensed for recycling.
- the polar phase (phase A) once separated from the glycerol by decantation (followed or not water washes), consisting mainly of alkyl esters and unsaponifiable (or not) polar compounds can then be engaged in molecular distillation to obtain on the one hand, purified esters (in the distillate) and d on the other hand, a distillation residue enriched in polar minor compounds.
- the extraction of these mainly unsaponifiable compounds is carried out according to the methods known to those skilled in the art.
- the apolar cosolvent is evaporated from the apolar phase enriched in lipids not containing hydroxyl, epoxide, ketone, thiol, aldehyde, ether and amine functions (or few of these functions) (unsaponifiable or not), especially under reduced pressure.
- the lipid product obtained may undergo a neutralization step (before or after the evaporation of the apolar cosolvent, preferably before), preferably with an acid, then a decantation or centrifugation step which makes it possible to recover residual glycerol on the one hand and a lipid phase on the other hand, and / or a filtration step.
- the remaining lipid phase can then be washed with water and dried under vacuum.
- the resulting lipid phase (phase containing typically alkyl esters and enriched in unsaponifiable (or not) apolar compounds) then undergoes a step c) of concentration to obtain a mixture enriched in unsaponifiable fraction.
- the preferred concentration technique is molecular distillation.
- Distillation generally makes it possible to obtain a light fraction (first distillate), comprising esters (typically alkyl) of high purity fatty acids, and at least one heavier fraction (second distillate or residue), comprising the unsaponifiable fraction diluted in esters (typically alkyl) fatty acids, present in a significant amount.
- first distillate comprising esters (typically alkyl) of high purity fatty acids
- second distillate or residue comprising the unsaponifiable fraction diluted in esters (typically alkyl) fatty acids
- the concentrate enriched in unsaponifiable fraction (and depleted in fatty acid esters) contains at this stage furan lipids (generally at a content of the order of 10-15% by weight), which are less volatile than monoesters of fatty acids. These furan compounds are present only in trace amounts in the light fraction essentially comprising fatty acid esters.
- the concentrate is then optionally subjected to stages d) saponification of the mixture enriched in unsaponifiable fraction and e) extraction of the unsaponifiable fraction of the saponified mixture.
- the unsaponifiable fraction is preferably purified, using the same techniques as those described for the first method of the invention.
- the second method according to the invention makes it possible to obtain an unsaponifiable fraction of high purity, enriched in low polar to apolar compounds.
- the unsaponifiable compounds obtained after the implementation of this process in the isolated fraction in fine may be, according to the nature of the raw material used, furan lipids (in the case of avocado ), sterol esters, esterified triterpene alcohols, cholesterol esters, tocopherols (and corresponding tocotrienols), sesamolin, sesamin, sterenes, squalene, paraffinic hydrocarbons, terpeno-polar to nonpolar terpenes (mono-, di and sesquiterpenes with an aldehyde and / or ketone function), esterified xanthophylls (lutein, astaxanthin, zeaxanthin), carotenoid-type pigments (beta-carotene, lycopene), waxes, calciferol, cholecalciferol, pongamol.
- furan lipids in the case of avocado
- sterol esters esterified triterpene alcohol
- the average composition of an unsaponifiable avocado obtained as a result of these different steps is as follows, in percentages by weight relative to the total mass of the product.
- unsaponifiable is:
- the unsaponifiable product obtained as described can then be subjected to a (second) distillation stage in order to further improve its purity, preferably a molecular distillation, preferably carried out at a temperature ranging from 100 to 160 ° C. more preferably from 100 to 140 ° C, preferably at a pressure of from 10 3 to 5 ⁇ 10 -2 mm Hg.
- This (second) distillation may make it possible to obtain a distillate comprising mainly, in the case of avocado, lipids avocado furans, the purity of which may exceed 90% by mass.
- This second method of the invention thus makes it possible to obtain a selective extraction of the furan lipids from the avocado, with the exception of the polyhydric fatty alcohols of avocado which have been extracted in the polar phase during the reactive trituration step .
- the unsaponifiable compounds obtained at the end of the implementation of this process in the fraction isolated from the polar solvent phase, in fine may be, according to the nature of the raw material used, the furan lipids (in the case of avocado), optionally polyhydroxy fatty alcohols, furanic lipids (in the case of avocado), non-esterified (free) or non-glycosylated sterols and triterpene alcohols, free and glycosylated polyphenols, free cholesterol or sulphated, lignans, phorbols esters, triterpenic acids (eg ursolic acid), polar terpenes (mono, di and sesquiterpenes, alcohol-based), alkaloids, polycosanols, limonoids, xanthophylls (free lutein, astaxanthin, zeaxanthin), gossypol, karanjine, shizandrin, azadirachtin, coenzyme Q10, aflatoxins
- the invention has many advantages over existing conventional methods used for extraction from oils or deodorization escapes.
- the method according to the invention is economical because it does not require the heavy investments of conventional methods.
- the process according to the invention makes it possible to dispense with mechanical trituration tools such as a screw press or a hexane extractor, and refining tools (degumming, neutralization).
- mechanical trituration tools such as a screw press or a hexane extractor
- refining tools degumming, neutralization
- the reactive trituration according to the invention does not involve high energy consumption. It also requires less freshwater consumption compared to crude oil refining operations.
- esters generally alkyl esters, of high purity, directly valued in cosmetics or pharmaceuticals (unlike previous processes involving a distillation step on a mixture containing triglycerides, such a distillation generating a highly colored oil and difficult to purify because requiring a higher temperature than that possibly used in the invention, which relates to a mixture containing monoesters of fatty acids from transesterification, lighter than triglycerides),
- glycerol which has applications in cosmetics, pharmacy, hygiene, antifreeze fluids, etc.
- the processes of the invention allow not only an almost total recovery of the fruit unlike current processes and in fact a saving of biomass, or even cultivated land, but they also make it possible to improve the whole. value chain, from the farmer upstream to the downstream user, said unsaponifiables. Finally, it is in line with the key principles of biorefinery models currently under development for multiple uses, in particular energy and industrial.
- the unsaponifiable fractions obtained by the processes of the invention have a composition very similar to, or even identical to that of the unsaponifiable material present in the raw material before treatment.
- these unsaponifiable fractions and these co-products according to the invention do not contain toxic residual solvent and therefore have a much better safety and regulatory acceptability than the products obtained by implementing processes. classics. These particular characteristics allow a more suitable use of unsaponifiable fractions obtained by the processes of the invention and / or co-products obtained in cosmetic, medicinal, food or food additive or food additive compositions for humans and / or animals.
- the process according to the invention will make it possible to separate and / or concentrate, according to their polarity, the contaminants that may be present in plant or animal biomasses: polycyclic aromatic hydrocarbons (PAHs), pesticides, polychlorinated biphenyls (PCBs), dioxins, agents brominated fireproof, pharmaceutical products, ....
- PAHs polycyclic aromatic hydrocarbons
- PCBs polychlorinated biphenyls
- dioxins agents brominated fireproof, pharmaceutical products, ....
- the unsaponifiable fraction of the avocado obtained by the processes of the invention may especially be used for the manufacture of a medicament intended for example for the treatment of disorders of the joints, more particularly the treatment of osteoarthritis and the treatment of arthritis ( ie rheumatoid arthritis, psoriatic arthritis, Lyme arthritis and / or any other type of arthritis).
- the drug thus prepared may be intended for the treatment of periodontal diseases, and in particular for the treatment of periodontitis. This medicine can also be used to treat osteoporosis.
- this drug may be intended to modulate the differentiation of nerve cells induced by NGF (Nerve Growth Factor).
- NGF Neve Growth Factor
- this drug may be intended for tissue repair, and in particular for skin tissue repair, particularly in the context of a dermatological application.
- the unsaponifiable fraction of the avocado resulting from the processes of the invention can also be used in cosmetic compositions, in particular dermo-cosmetic compositions, for the cosmetic treatment of the skin, neighboring mucous membranes and / or integuments (aging, scars, etc.). .), hair fibers or hair bulb, in the presence of an excipient and / or cosmetically acceptable vehicle.
- the process co-products such as proteins and carbohydrates can, depending on their nature, be used as such or after processing to produce active ingredients or excipients intended in particular for pharmaceuticals, cosmetics and nutrition. to the man or the animal.
- Lot A is then subject to the following actions:
- the biphasic miscella is then centrifuged so as to separate the ethanolic and hexane phases.
- the solvents of the 2 recovered organic phases are then evaporated under a vacuum of 20 mbar at 90 ° C. for 20 minutes.
- the glycerol is then separated from the ex-ethanolic lipid phase by simple centrifugation.
- Thin layer chromatographic analysis indicates that lipids contain only a few traces of polyhydroxy fatty alcohols from avocado and furan precursors.
- TLC thin layer chromatographic analysis
- the extraction process used makes it possible to selectively extract the polar compounds from the unsaponifiable dried avocado (TLC spots characteristic of polyhydroxy fatty alcohols and the presence of furan lipids resulting from the cyclization of the furan precursors resulting from the heat treatment) and this, with an excellent yield (unsaponifiable content much higher than 4%).
- the unsaponifiable fraction is then washed, dried, concentrated by molecular distillation, saponified, extracted and purified according to the same protocol as that of Example No. 2 of the application WO 201 1/048339.
- the biphasic miscella is then centrifuged so as to separate the ethanolic and hexane phases.
- the 2 recovered organic phases are then evaporated under a vacuum of 20 mbar at 90 ° C. for 20 minutes.
- the glycerol is separated from the ex-ethanolic lipid phase by simple centrifugation.
- unsaponifiable content (modified NF ISO 3596 method in which the extraction solvent is dichloroethane): 5.3%.
- a thin layer chromatographic analysis indicates that the lipids of the hexane phase consist mainly of furanic lipids and some traces of polyhydric fatty alcohols.
- the process results in an apolar lipid phase enriched in furan lipids and depleted in unsaponifiable avocado polar compounds such as polyhydric fatty alcohols.
- Lipids from the ethanolic phase are analyzed by thin layer chromatography (TLC). This analysis indicates that this phase contains in large quantities the polyhydroxy fatty alcohols of the avocado as well as traces of furan lipids.
- the extraction process used makes it possible to extract the polar compounds selectively from the unsaponifiable dried avocado (TLC spots characteristic of polyhydroxy fatty alcohols).
- the unsaponifiable fraction of the lipids resulting from the hexane phase is then washed, dried, concentrated by molecular distillation, saponified, extracted and purified according to the same protocol as that of Example No. 2 of the application WO 201 1/043339.
- a TLC analysis of the unsaponifiable material obtained reveals the characteristic spots of furan lipids (very intense spots), hydroxylated fatty alcohols (very weak spots) and phytosterols (very weak spots).
- the process leads to delipid cake enriched in fact, proteins and polysaccharides sources of active principles and / or excipents or can still be used as such in human and animal nutrition.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Fats And Perfumes (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Extraction Or Liquid Replacement (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1355140A FR3006327B1 (en) | 2013-06-04 | 2013-06-04 | METHODS OF SELECTIVELY EXTRACTING THE INSAPONIFIABLES OF RAW MATERIALS REACTIVE TRITURING IN THE PRESENCE OF A COSOLVANT |
| PCT/FR2014/051328 WO2014195637A1 (en) | 2013-06-04 | 2014-06-04 | Processes for selective extraction of unsaponifiable materials from renewable raw materials by reactive trituration in the presence of a cosolvent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP3004299A1 true EP3004299A1 (en) | 2016-04-13 |
Family
ID=48795823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP14733255.5A Withdrawn EP3004299A1 (en) | 2013-06-04 | 2014-06-04 | Processes for selective extraction of unsaponifiable materials from renewable raw materials by reactive trituration in the presence of a cosolvent |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20160108013A1 (en) |
| EP (1) | EP3004299A1 (en) |
| JP (1) | JP2016522293A (en) |
| CN (1) | CN105452428A (en) |
| CA (1) | CA2914466A1 (en) |
| FR (1) | FR3006327B1 (en) |
| WO (1) | WO2014195637A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3039063B1 (en) | 2015-07-22 | 2017-07-21 | Biosynthis Sarl | PROCESS FOR ENRICHING PONGAMOL WITH KARANJA OIL |
| CN118696989A (en) * | 2018-05-03 | 2024-09-27 | 可更新能源集团 | Method for producing purified biodiesel or simultaneously recovering valuable chemicals |
| CN109232229B (en) * | 2018-10-31 | 2024-05-28 | 湖南朗林生物资源股份有限公司 | Preparation method of rosemary extract |
| EP3756474B1 (en) * | 2019-06-25 | 2024-03-06 | Analyticon Discovery GmbH | An extract of persea |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2669239B1 (en) | 1990-11-21 | 1993-06-18 | Electricite De France | MOLECULAR DISTILLATION APPARATUS WITH INDUCTION HEATING. |
| FR2678632B1 (en) | 1991-07-03 | 1994-09-02 | Pharmascience Lab | PROCESS FOR THE PREPARATION OF THE UNSAPONIFIABLE LAWYER FOR IMPROVING ITS CONTENT IN ONE OF ITS FRACTIONS SAID H |
| FR2798667B1 (en) * | 1999-09-22 | 2001-12-21 | Pharmascience Lab | PROCESS FOR THE EXTRACTION OF FURANIC COMPOUNDS AND POLYHYDROXYL FATTY ALCOHOLS FROM LAWYER, COMPOSITION BASED ON AND USE OF THESE COMPOUNDS IN THERAPEUTICS, COSMETICS AND FOOD |
| WO2004016106A1 (en) * | 2002-07-29 | 2004-02-26 | Laboratoires Expanscience | Method for producing an unsaponifiable matter of avocado rich in furan lipids |
| KR20120053088A (en) | 2006-05-26 | 2012-05-24 | 아미리스 인코퍼레이티드 | Production of isoprenoids |
| FR2941228B1 (en) | 2009-01-20 | 2011-02-25 | Arkema France | METHOD FOR OBTAINING A FRACTION ENRICHED INTO ESTERS OF FUNCTIONALIZED FATTY ACIDS FROM OLEAGINOUS PLANT SEEDS |
| FR2951736B1 (en) * | 2009-10-23 | 2011-12-30 | Valagro Carbone Renouvelable Poitou Charentes | PROCESS FOR EXTRACTING THE INSAPONIFIABLE FROM RENEWABLE RAW MATERIALS |
| FR2955784B1 (en) * | 2010-01-29 | 2014-02-14 | Expanscience Lab | LIQUID / LIQUID EXTRACTION |
| CN102787074B (en) | 2011-05-20 | 2016-06-08 | 罗盖特兄弟公司 | New strain of microalgae that produces squalene |
-
2013
- 2013-06-04 FR FR1355140A patent/FR3006327B1/en not_active Expired - Fee Related
-
2014
- 2014-06-04 CA CA2914466A patent/CA2914466A1/en not_active Abandoned
- 2014-06-04 US US14/895,865 patent/US20160108013A1/en not_active Abandoned
- 2014-06-04 WO PCT/FR2014/051328 patent/WO2014195637A1/en not_active Ceased
- 2014-06-04 JP JP2016517661A patent/JP2016522293A/en active Pending
- 2014-06-04 EP EP14733255.5A patent/EP3004299A1/en not_active Withdrawn
- 2014-06-04 CN CN201480038887.1A patent/CN105452428A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2014195637A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014195637A1 (en) | 2014-12-11 |
| CN105452428A (en) | 2016-03-30 |
| FR3006327A1 (en) | 2014-12-05 |
| JP2016522293A (en) | 2016-07-28 |
| FR3006327B1 (en) | 2015-06-05 |
| US20160108013A1 (en) | 2016-04-21 |
| CA2914466A1 (en) | 2014-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3004301A1 (en) | Processes for selective extraction of unsaponifiable materials from renewable raw materials by solid-liquid extraction in the presence of a cosolvent | |
| EP1213975B1 (en) | Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado | |
| EP2528458B1 (en) | Solid/liquid extraction | |
| EP2491100B1 (en) | Process for the extraction of unsaponifiable matter from renewable raw material. | |
| EP2882841B1 (en) | Method for preparing a composition rich in lutein produced by microalgae | |
| EP3004300A1 (en) | Processes for selective extraction of unsaponifiable materials from renewable raw materials by liquid-liquid extraction in the presence of a cosolvent | |
| CA2989041C (en) | Liquid/liquid extraction | |
| EP3004299A1 (en) | Processes for selective extraction of unsaponifiable materials from renewable raw materials by reactive trituration in the presence of a cosolvent | |
| EP3362078B1 (en) | Novel organic solubilisation and/or extraction solvent, extraction method using said solvent, and extracts obtained by said method | |
| WO2013014344A2 (en) | Liquid/liquid extraction with a solvent comprising at least 5 carbon atoms and 1 or 2 oxygen atoms | |
| CA2843082C (en) | Solid/liquid extraction using a solvent comprising 5 to 8 carbon atoms and 1 or 2 oxygen atoms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20151204 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: C11B 3/06 20060101ALI20161004BHEP Ipc: C11B 1/04 20060101AFI20161004BHEP Ipc: C11B 3/00 20060101ALI20161004BHEP Ipc: C11B 1/10 20060101ALI20161004BHEP Ipc: C11B 7/00 20060101ALI20161004BHEP Ipc: C11C 1/10 20060101ALI20161004BHEP |
|
| INTG | Intention to grant announced |
Effective date: 20161020 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20170301 |